ADAM9 and infection: It has been proposed as a biomarker for tissue damage and shown to be of particular use in excluding a confounding effect of an infection, as in vitro exposure to pathogen-associated molecular patterns (PAMPs) leads to a very limited change in the expression of ADAM9, in contrast to many other biomarkers.